ViiV Healthcare understands this push-and-pull dynamic all too well and sought out to do something about it. “Both sides are waiting for the other person to initiate and take the lead in those deeper ...
The FDA has approved Rukobia, a first-in-class drug from ViiV Healthcare intended for older people with HIV, who have been on antiretroviral therapy (ART) for so long it is starting to fail.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback